notaris007 schreef op 28 april 2017 15:01:
Van de website:
www.genengnews.com/gen-news-highlight..."MDxHealth, Exact Agree to Collaborate on Epigenetics and MDx
MDxHealth and Exact Sciences say they will share their respective epigenetic and molecular diagnostic technologies and R&D through a 5-year collaboration agreement with the ultimate goal of developing new epigenetic-based diagnostics for a range of indications, including urology and lung cancer.
"The collaboration may allow each party to better capitalize on its cutting-edge epigenetic research and development efforts to bring new products and services to market to improve patient lives,” commented Wim van Criekinge, Ph.D., CSO at MDxHealth, which has its U.S. headquarters in Irvine, CA."